INTRODUCTION AND OBJECTIVES:
Epidural anesthesia is used to improve pain control after major surgery and has been associated with improved survival in some non-urologic cancers. Perioperative epidural use may reduce recurrence of non-muscle invasive bladder cancer. However, few data describe the impact of epidural use for bladder cancer patients treated with radical cystectomy. Here, we evaluate epidural use on perioperative and long-term outcomes for patients treated with radical cystectomy for bladder cancer.
METHODS: Patients who received radical cystectomy for nonmetastatic bladder urothelial carcinoma with epidural (n[1,748) and without epidural (n[6,109) anesthesia from 2002-2014 were identified using Surveillance, Epidemiology and End Results-Medicare data. Radical cystectomy outcomes with and without epidural anesthesia were compared using propensity score weighting.
RESULTS: Epidural use at time of radical cystectomy was identified in 1,748 (22.2%) of 7,857 patients who met inclusion criteria. After propensity score weighted adjustment, epidural use was associated with increased 30-day readmission (29.6% vs. 26.2%, p<0.001), increased median length of stay in days (9.0, IQR 7.0-12.0 vs 8.0, IQR 6.0-12.0, p<0.01), and decreased likelihood of being discharged directly to home without need for home health or skilled nursing care (21.6% vs 29.1%, p<0.001). Post operative MI (2.6% vs 1.3%, p<0.001) and stroke (4.7% vs 3.9%, p[0.028 in the first 30 days after radical cystectomy was more common in the epidural group, but perioperative 30-day mortality was similar (3.3% vs 2.9%, p[0.205). Epidural use was not associated with increased cancer specific (HR 0.96, p[0.20) or overall survival (HR 0.99, p[0.73) .
CONCLUSIONS: Epidural use at time of radical cystectomy is associated with increased risk of perioperative complications, hospital readmission, and longer hospitalization without improving disease specific survival.
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Devanshu Bansal, Brusabhanu Nayak*, Prabhjot Singh, Rishi Nayyar, Amlesh Seth, Rashmi Ramachandran, New Delhi, India INTRODUCTION AND OBJECTIVES: Introduction -Radical cystectomy for invasive bladder carcinoma is associated with significant perioperative morbidity. Enhanced recovery after surgery (ERAS) protocols aim to expedite post-operative recovery. There is limited data in the Indian setting regarding the use of ERAS protocol after radical cystectomy.
Objective: To evaluate if hospital stay and 30-day perioperative outcomes and complications were improved with implementation of ERAS protocols.
METHODS: This prospective randomized controlled trial enrolled 54 patients undergoing open radical cystectomy from April 2017 till May 2018 at a tertiary care centre in India. Follow-up was done till 30-days postoperatively or till discharge, whichever longer.
Patients in ERAS group received peri-operative care according to ERAS protocol (table 1). Postoperative length of stay, bowel recovery, pain and peri-operative morbidity and mortality data was collected.
RESULTS: 25 Patients in each group were analysed. Length of stay was similar (8 (5-57) vs 9 days (5-19), p-value 0.470). Bowel recovery was significantly faster in ERAS group (12 (12-108) vs 36 hours (12-60) for bowel sounds (p-value 0.001), 60 (12-108) vs 72 hours (36-156) for flatus (p-value 0.001) and 84 (36-180) vs 96 (60-156) for stools (p-value 0.030)). Minor and major 30-day post-operative complications (14 (56%) vs 13 (52%), p-value 0.777) and re-admission (1 (4%) vs 2 (8%), p-value 0.99) were similar. The main limitation of the study was w72.2% compliance with ERAS protocols. Detailed results in table 2.
CONCLUSIONS: Use of ERAS protocols are a viable and possibly preferred option in patients following radical cystectomy and urinary diversion and it enhances post operative recovery.
